Realities and opportunities of multiple-task mammographic screening in maintaining women’s health

New applications of X-ray mammography in dispensary examinations, extending beyond traditional oncological screening, are presented. The established regulatory algorithm for breast examination is outlined, along with emerging opportunities to detect two major health issues in women– breast cancer and cardiovascular disease – through the identification of arterial wall calcifications on mammograms. The importance of early recognition of benign breast dysplasia is also emphasized, as timely pathogenetic treatment can reduce the risk of malignant transformation. By addressing multiple women’s health concerns within the framework of mammography screening, this approach improves cost-effectiveness by minimizing the need for additional facilities, equipment, staff, and patient management resources.

1. Kaprin A. D., Rozhkova N. I. Mammology: national guidelines. M.: GEOTAR-Med., 2025. 590 p.

2. Atkinson S, Neep M, Starkey D. Reject rate analysis in digital radiography: an Australian emergency imaging department case study. J Med Radiat Sci. 2020; 67: 72–79. https://doi.org/10.1002/jmrs.343

3. Available via https://healthcare-quality.jrc.ec.europa.eu/european-breast-cancer-guidelines/screening-ages-and-frequencies/women‑50–69. Accessed 21 July 2021 European Radiology. 2022; 32: 7278–7294.

4. Kavousi M, Desai CS, Ayers C. et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA. 2016; 316 (20): 2126–34. DOI: 10.1001/jama.2016.17020

5. Hendriks E. J.E, de Jong P. A. van der Graaf Y. et al. Breast arterial calcifications: A systematic review and meta-analysis of their determinants and their association with cardiovascular events. Atherosclerosis. 2015: 239 (1): 11–20. DOI: 10.1016/j.atherosclerosis.2014.12.035

6. Lee SC, Phillips M, Bellinge J. et al. Is breast arterial calcification associated with coronary artery disease?-A systematic review and meta-analysis. PLoS One. 2020; 15 (7): e0236598.

7. Kelly BS, Scanlon E, Heneghan H. et al. Breast arterial calcification on screening mammography can predict significant coronary artery disease in women. Clin Imaging. 2017; 49: 48–53. https://doi.org/10.1016/j.clinimag.2017.10.021

8. Karm D, Marks DS, Wein M, Kong AL. Benign arterial calcification on screening mammogram: a marker for coronary artery disease? J Womens Health (Larchmt). 2015; 24: 795–800.

9. Iribarren C, Chandra M, Lee C, Sanchez G, Sam DL, Azamian FF, Cho HM, Ding H, Wong ND, Molloi S. Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women. Circ Cardiovasc Imaging. 2022 Mar; 15 (3): e013526. DOI: 10.1161/CIRCIMAGING.121.013526

10. Nudy M, Asmaro R, Jiang X, Schnatz PF. The association between incidentally found breast arterial calcification on routine screening mammography and the development of coronary artery disease and stroke: results of a 10-year prospective study. Menopause. 2022 Dec 1; 29 (12): 1375–1380. DOI: 10.1097/GME.0000000000002088

11. Iribarren C, Chandra M, Parikh RV. et al. Breast arterial calcification is associated with incident atrial fibrillation among older but not younger post-menopausal women. European Heart Journal Open. 2023; 3: 1–9. https://doi.org/10.1093/ehjopen/oead017

12. Bochkareva E. V., Butina E. K., Savin A. S., Stulin I. D., Trukhanov S. A., Drapkina O. M. Mammary arterial calcification: a potential surrogate marker for cerebrovascular diseases. Preventive Medicine. 2020; 23 (5): 183–188. (In Russ.). https:// doi.org/10.17116/profmed202023051183Е

13. Nudy M, Asmaro R, Jiang X, Schnatz PF. The association between incidentally found breast arterial calcification on routine screening mammography and the development of coronary artery disease and stroke: results of a 10-year prospective study. Menopause. 2022 Dec 1; 29 (12): 1375–1380. DOI: 10.1097/GME.0000000000002088

14. Allen TS, Bui QM, Petersen GM, Mantey R, Wang J, Nerlekar N, Eghtedari M, Daniels LB. Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality. JACC Adv. 2024 Sep 27; 3 (11): 101283. DOI: 10.1016/j.jacadv.2024.101283

15. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990 Mar 15; 15 (4): 827–32. DOI: 10.1016/0735-1097(90)90282-t

16. Drapkina O. M., Kaprin A. D., Almazova I. I., Drozdova L. Yu., Ivanova E. S., Rozhkova N. I., Rubtsova N. A., Khailova Zh.V., Shepel R. N. Screening for malignant neoplasms of the mammary gland as part of the medical examination of certain groups of the adult population. Methodological recommendations. Primary health care. 2024; 1 (1): 63–80. (In Russ.). DOI: 10.15829/3034‑4123‑2024‑5. ISSN 3034–4123 (Print) ISSN (Online).

17. Rodionov V. V., Smetnik A. A. Benign diseases of the mammary glands. Obstetrics and Gynecology: News. Opinions. Training. 2018; 1 (19). (In Russ.).

18. Andreeva E. N., Rozhkova N. I. Efficacy of a transdermal gel containing micronized progesterone in the treatment of fibrocystic breast disease (FCM). Results of a Russian study. Obstetrics and Gynecology. 2016. (In Russ.).

19. Protasova A. E. Dynamics of clinical symptoms of fibrocystic mastopathy during monotherapy with transdermal micronized progesterone: results of the BREST‑2 multicenter cohort study. Obstetrics and Gynecology. 2020. (In Russ.).

20. Vysotskaya I. V., Letyagin V. P., Laktionov K. P. Diagnosis and treatment of benign breast diseases (clinical guidelines of the Russian Society of Oncomammologists). Tumors of the female reproductive system. 2014: 19–32. (In Russ.).

21. Clinical guidelines «Benign dysplasia of the mammary glands». Moscow, 2024. (In Russ.).

22. Rozhkova N. I., Burdina I. I., Zapirova S. B., Zikiryakhodzhaev A. D., Ermoschenkova M. V., Mazo M. L., Prokopenko S. P., Sukhotko A. S., Jacobs O. E., Semikopenko V. A., Kiselev V. I. Benign diseases of the mammary gland. 1st ed. Moscow: GEOTAR-Media, 2017. (In Russ.).

23. Ashrafyan L. A., Rozhkova N. I., Prokopenko S. P. et al. Effect of indolecarbinol on the course of cyclic mastalgia associated with benign breast dysplasia in routine clinical practice (the APHRODITE study). Obstetrics and Gynecology. 2024; 2: 134–142. (In Russ.).

24. Breast density assessment via quantitative sound-speed measurement using conventional ultrasound transducers Can Deniz Bezek, Monika Farkas, Dieter Schweizer, Rahel A. Kubik-Huch2 and Orcun Goksel1,3. European Radiology. 2025; 35: 1478–1489. https://doi.org/10.1007/s00330‑024‑11085‑9

25. Labazanova P. G., Rozhkova N. I., Burdina I. I., Zapirova S. B., Mazo M. L., Mikushin M. Yu., Prokopenko S. P., Jacobs O. E. Mammographic density and the risk of developing breast cancer. A look at the history of studying the issue. REJR Russian Electronic Journal of Radiology. 2020; 10 (2): 205–222. (In Russ.).

26. Labazanova P. G., Budanova M. V., Burdina I. I., Zapirova S. B., Mazo M. L., Mikushin S. Yu., Prokopenko S. P., Rozhkova N. I. Mammographic density as a marker of increased risk of breast cancer. Medical alphabet. Diagnostics and oncotherapy. 2021; 19: 41–48. (In Russ.).

27. Yonggeng Goh, Chen-Pin Chou, Ching Wan Chan, Shaik Ahmad Buhari, Mikael Hartman, Siau Wei Tang, Celene Wei Qi Ng, Premilla Pillay, Wynne Chua, Pooja Jagmohan, Eide Sterling, Ying Mei Wong, Loon Ying Tan, Han Yang Ong, Huay-Ben Pan, Herng-Sheng Lee, Bao-Hui Hung & Swee Tian Quek Impact of contrast-enhanced mammography in surgical management of breast cancers for women with dense breasts: a dual-center, multi-disciplinary study in Asia. European Radiology. 2022; 32: 8226–8237.

28. Bischoff-Kont I, Brabenec L, Ingelfinger R, Nausch B, Fürst R. BNO 1095, a standardized dry extract from the fruits of Vitex agnus-castus, impairs angiogenesis-related endothelial cell functions in vitro. Planta Med. 2021; 87 (8): 611–619. DOI: 10.1055/a‑1351-1038

29. Kaprin A. D., Rozhkova N. I. Benign diseases of the mammary gland / edited by A. D. Kaprin, N. I. Rozhkova. Moscow: GEOTAR-Media, 2019. 272 p. (In Russ.).

30. Kiselev V. I., Sidorova I. S., Unanyan A. L., Muyzhnek E. L. (2011) Hyperplastic processes of the female reproductive system: theory and practice (monograph). Moscow: Medpraktika-M. (In Russ.).

31. Kiselev V. I., Smetnik V. P., Suturina L. V. et al. Indolecarbinol (Indinol Forte) – a method of multitarget therapy for cyclic mastodynia. Obstetrics and Gynecology. 2013; 7: 56–62. (In Russ.).

32. Levakov S. A., Kaviladze M. G., Gelashvili A. Z. Efficiency of Indinol Forte in patients with dyshormonal diseases of the mammary glands. Pharmacology and Pharmacotherapy. 2022; (1): 90–9. (In Russ.). DOI: 10.46393/27132129_2022_1_90

33. Bradlow HL, Michnovicz JJ, Halper M et al. Long-term responses of women to indole‑3-carbinol or a high fiber diet. Cancer Epidimiol Biomarkers Prev. 1994; 3(7): 591–595.

34. Fujioka N, Fritz V, Upadhyaya P. et al. Research on cruciferous vegetables, indole‑3-carbinol, and cancer prevention: a tribute to Lee W. Wattenberg. Mol Nutr Food Res. 2016; 60 (6): 1228–1238.

35. Shabaev R. M., Kolyadina I. V., Blagovestnov D. A., Starokon P. M. Evaluation of the clinical and radiological effectiveness of a new conservative method for the treatment of fibrocystic disease. Tumors of the female reproductive system. 2023; 19 (4): 36–42. (In Russ.). https://doi.org/10.17650/1994‑4098‑2023‑19‑4‑36‑42

36. Shabaev R. M., Kolyadina I. V., Blagovestnov D. A., Starokon P. M. Risk factors for breast cancer development against the background of a long-term course of benign breast diseases: a 10-year observational study. Tumors of the female reproductive system. 2024; 20 (1): 31–38. (In Russ.). https://doi.org/10.17650/1994‑4098‑2024‑20‑1‑31‑38

37. Мастопатии / под ред. А. Д. Каприна, Н. И. Рожковой. М.: ГЭОТАР-Медиа. Mastopathy / edited by A. D. Kaprin, N. I. Rozhkova. Moscow: GEOTAR-Media. (In Russ.).